インスリン様成長因子のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Insulin Like Growth Factor Market Insights and Forecast to 2028

• レポートコード：QY2203B01666
• 出版社/出版日：QYResearch / 2022年3月
• レポート形態：英文、PDF、73ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のインスリン様成長因子の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にインスリン様成長因子の世界市場のxxx％を占める「メカノグロースファクター」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のインスリン様成長因子の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのインスリン様成長因子市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのインスリン様成長因子市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

インスリン様成長因子のグローバル主要メーカーには、Boehringer Ingelheim GmbH、Genervon Biopharmaceuticals LLC、MedImmune LLC、Regulaxis SASなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

インスリン様成長因子市場は、種類と用途によって区分されます。世界のインスリン様成長因子市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
メカノグロースファクター、ソマトメジンC、IGF1

【用途別セグメント】
病院、医療センター

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- インスリン様成長因子製品概要
- 種類別市場（メカノグロースファクター、ソマトメジンC、IGF1）
- 用途別市場（病院、医療センター）
- 調査の目的
・エグゼクティブサマリー
- 世界のインスリン様成長因子販売量予測2017-2028
- 世界のインスリン様成長因子売上予測2017-2028
- インスリン様成長因子の地域別販売量
- インスリン様成長因子の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別インスリン様成長因子販売量
- 主要メーカー別インスリン様成長因子売上
- 主要メーカー別インスリン様成長因子価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（メカノグロースファクター、ソマトメジンC、IGF1）
- インスリン様成長因子の種類別販売量
- インスリン様成長因子の種類別売上
- インスリン様成長因子の種類別価格
・用途別市場規模（病院、医療センター）
- インスリン様成長因子の用途別販売量
- インスリン様成長因子の用途別売上
- インスリン様成長因子の用途別価格
・北米市場
- 北米のインスリン様成長因子市場規模（種類別、用途別）
- 主要国別のインスリン様成長因子市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのインスリン様成長因子市場規模（種類別、用途別）
- 主要国別のインスリン様成長因子市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のインスリン様成長因子市場規模（種類別、用途別）
- 主要国別のインスリン様成長因子市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のインスリン様成長因子市場規模（種類別、用途別）
- 主要国別のインスリン様成長因子市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのインスリン様成長因子市場規模（種類別、用途別）
- 主要国別のインスリン様成長因子市場規模（トルコ、サウジアラビア）
・企業情報
Boehringer Ingelheim GmbH、Genervon Biopharmaceuticals LLC、MedImmune LLC、Regulaxis SAS
・産業チェーン及び販売チャネル分析
- インスリン様成長因子の産業チェーン分析
- インスリン様成長因子の原材料
- インスリン様成長因子の生産プロセス
- インスリン様成長因子の販売及びマーケティング
- インスリン様成長因子の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- インスリン様成長因子の産業動向
- インスリン様成長因子のマーケットドライバー
- インスリン様成長因子の課題
- インスリン様成長因子の阻害要因
・主な調査結果

Market Analysis and Insights: Global Insulin Like Growth Factor Market
Due to the COVID-19 pandemic, the global Insulin Like Growth Factor market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Mechano Growth Factor accounting for % of the Insulin Like Growth Factor global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Insulin Like Growth Factor market size is valued at US$ million in 2021, while the US and Europe Insulin Like Growth Factor are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Insulin Like Growth Factor landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Insulin Like Growth Factor include Boehringer Ingelheim GmbH, Genervon Biopharmaceuticals LLC, MedImmune LLC and Regulaxis SAS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Insulin Like Growth Factor Scope and Segment
Insulin Like Growth Factor market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Insulin Like Growth Factor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Mechano Growth Factor
Somatomedin C
IGF1
Segment by Application
Hospital
Medical Center
By Company
Boehringer Ingelheim GmbH
Genervon Biopharmaceuticals LLC
MedImmune LLC
Regulaxis SAS
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

1 Study Coverage
1.1 Insulin Like Growth Factor Product Introduction
1.2 Market by Type
1.2.1 Global Insulin Like Growth Factor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Mechano Growth Factor
1.2.3 Somatomedin C
1.2.4 IGF1
1.3 Market by Application
1.3.1 Global Insulin Like Growth Factor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Medical Center
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Insulin Like Growth Factor Sales Estimates and Forecasts 2017-2028
2.2 Global Insulin Like Growth Factor Revenue Estimates and Forecasts 2017-2028
2.3 Global Insulin Like Growth Factor Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Insulin Like Growth Factor Sales by Region
2.4.1 Global Insulin Like Growth Factor Sales by Region (2017-2022)
2.4.2 Global Sales Insulin Like Growth Factor by Region (2023-2028)
2.5 Global Insulin Like Growth Factor Revenue by Region
2.5.1 Global Insulin Like Growth Factor Revenue by Region (2017-2022)
2.5.2 Global Insulin Like Growth Factor Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Insulin Like Growth Factor Sales by Manufacturers
3.1.1 Global Top Insulin Like Growth Factor Manufacturers by Sales (2017-2022)
3.1.2 Global Insulin Like Growth Factor Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Insulin Like Growth Factor in 2021
3.2 Global Insulin Like Growth Factor Revenue by Manufacturers
3.2.1 Global Insulin Like Growth Factor Revenue by Manufacturers (2017-2022)
3.2.2 Global Insulin Like Growth Factor Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Like Growth Factor Revenue in 2021
3.3 Global Insulin Like Growth Factor Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Insulin Like Growth Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Insulin Like Growth Factor Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Insulin Like Growth Factor Sales by Type
4.1.1 Global Insulin Like Growth Factor Historical Sales by Type (2017-2022)
4.1.2 Global Insulin Like Growth Factor Forecasted Sales by Type (2023-2028)
4.1.3 Global Insulin Like Growth Factor Sales Market Share by Type (2017-2028)
4.2 Global Insulin Like Growth Factor Revenue by Type
4.2.1 Global Insulin Like Growth Factor Historical Revenue by Type (2017-2022)
4.2.2 Global Insulin Like Growth Factor Forecasted Revenue by Type (2023-2028)
4.2.3 Global Insulin Like Growth Factor Revenue Market Share by Type (2017-2028)
4.3 Global Insulin Like Growth Factor Price by Type
4.3.1 Global Insulin Like Growth Factor Price by Type (2017-2022)
4.3.2 Global Insulin Like Growth Factor Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Insulin Like Growth Factor Sales by Application
5.1.1 Global Insulin Like Growth Factor Historical Sales by Application (2017-2022)
5.1.2 Global Insulin Like Growth Factor Forecasted Sales by Application (2023-2028)
5.1.3 Global Insulin Like Growth Factor Sales Market Share by Application (2017-2028)
5.2 Global Insulin Like Growth Factor Revenue by Application
5.2.1 Global Insulin Like Growth Factor Historical Revenue by Application (2017-2022)
5.2.2 Global Insulin Like Growth Factor Forecasted Revenue by Application (2023-2028)
5.2.3 Global Insulin Like Growth Factor Revenue Market Share by Application (2017-2028)
5.3 Global Insulin Like Growth Factor Price by Application
5.3.1 Global Insulin Like Growth Factor Price by Application (2017-2022)
5.3.2 Global Insulin Like Growth Factor Price Forecast by Application (2023-2028)
6 North America
6.1 North America Insulin Like Growth Factor Market Size by Type
6.1.1 North America Insulin Like Growth Factor Sales by Type (2017-2028)
6.1.2 North America Insulin Like Growth Factor Revenue by Type (2017-2028)
6.2 North America Insulin Like Growth Factor Market Size by Application
6.2.1 North America Insulin Like Growth Factor Sales by Application (2017-2028)
6.2.2 North America Insulin Like Growth Factor Revenue by Application (2017-2028)
6.3 North America Insulin Like Growth Factor Market Size by Country
6.3.1 North America Insulin Like Growth Factor Sales by Country (2017-2028)
6.3.2 North America Insulin Like Growth Factor Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Insulin Like Growth Factor Market Size by Type
7.1.1 Europe Insulin Like Growth Factor Sales by Type (2017-2028)
7.1.2 Europe Insulin Like Growth Factor Revenue by Type (2017-2028)
7.2 Europe Insulin Like Growth Factor Market Size by Application
7.2.1 Europe Insulin Like Growth Factor Sales by Application (2017-2028)
7.2.2 Europe Insulin Like Growth Factor Revenue by Application (2017-2028)
7.3 Europe Insulin Like Growth Factor Market Size by Country
7.3.1 Europe Insulin Like Growth Factor Sales by Country (2017-2028)
7.3.2 Europe Insulin Like Growth Factor Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Insulin Like Growth Factor Market Size by Type
8.1.1 Asia Pacific Insulin Like Growth Factor Sales by Type (2017-2028)
8.1.2 Asia Pacific Insulin Like Growth Factor Revenue by Type (2017-2028)
8.2 Asia Pacific Insulin Like Growth Factor Market Size by Application
8.2.1 Asia Pacific Insulin Like Growth Factor Sales by Application (2017-2028)
8.2.2 Asia Pacific Insulin Like Growth Factor Revenue by Application (2017-2028)
8.3 Asia Pacific Insulin Like Growth Factor Market Size by Region
8.3.1 Asia Pacific Insulin Like Growth Factor Sales by Region (2017-2028)
8.3.2 Asia Pacific Insulin Like Growth Factor Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Insulin Like Growth Factor Market Size by Type
9.1.1 Latin America Insulin Like Growth Factor Sales by Type (2017-2028)
9.1.2 Latin America Insulin Like Growth Factor Revenue by Type (2017-2028)
9.2 Latin America Insulin Like Growth Factor Market Size by Application
9.2.1 Latin America Insulin Like Growth Factor Sales by Application (2017-2028)
9.2.2 Latin America Insulin Like Growth Factor Revenue by Application (2017-2028)
9.3 Latin America Insulin Like Growth Factor Market Size by Country
9.3.1 Latin America Insulin Like Growth Factor Sales by Country (2017-2028)
9.3.2 Latin America Insulin Like Growth Factor Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Insulin Like Growth Factor Market Size by Type
10.1.1 Middle East and Africa Insulin Like Growth Factor Sales by Type (2017-2028)
10.1.2 Middle East and Africa Insulin Like Growth Factor Revenue by Type (2017-2028)
10.2 Middle East and Africa Insulin Like Growth Factor Market Size by Application
10.2.1 Middle East and Africa Insulin Like Growth Factor Sales by Application (2017-2028)
10.2.2 Middle East and Africa Insulin Like Growth Factor Revenue by Application (2017-2028)
10.3 Middle East and Africa Insulin Like Growth Factor Market Size by Country
10.3.1 Middle East and Africa Insulin Like Growth Factor Sales by Country (2017-2028)
10.3.2 Middle East and Africa Insulin Like Growth Factor Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Boehringer Ingelheim GmbH
11.1.1 Boehringer Ingelheim GmbH Corporation Information
11.1.2 Boehringer Ingelheim GmbH Overview
11.1.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boehringer Ingelheim GmbH Recent Developments
11.2 Genervon Biopharmaceuticals LLC
11.2.1 Genervon Biopharmaceuticals LLC Corporation Information
11.2.2 Genervon Biopharmaceuticals LLC Overview
11.2.3 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Genervon Biopharmaceuticals LLC Recent Developments
11.3 MedImmune LLC
11.3.1 MedImmune LLC Corporation Information
11.3.2 MedImmune LLC Overview
11.3.3 MedImmune LLC Insulin Like Growth Factor Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 MedImmune LLC Insulin Like Growth Factor Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 MedImmune LLC Recent Developments
11.4 Regulaxis SAS
11.4.1 Regulaxis SAS Corporation Information
11.4.2 Regulaxis SAS Overview
11.4.3 Regulaxis SAS Insulin Like Growth Factor Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Regulaxis SAS Insulin Like Growth Factor Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Regulaxis SAS Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Insulin Like Growth Factor Industry Chain Analysis
12.2 Insulin Like Growth Factor Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Insulin Like Growth Factor Production Mode & Process
12.4 Insulin Like Growth Factor Sales and Marketing
12.4.1 Insulin Like Growth Factor Sales Channels
12.4.2 Insulin Like Growth Factor Distributors
12.5 Insulin Like Growth Factor Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Insulin Like Growth Factor Industry Trends
13.2 Insulin Like Growth Factor Market Drivers
13.3 Insulin Like Growth Factor Market Challenges
13.4 Insulin Like Growth Factor Market Restraints
14 Key Findings in The Global Insulin Like Growth Factor Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Insulin Like Growth Factor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Mechano Growth Factor
Table 3. Major Manufacturers of Somatomedin C
Table 4. Major Manufacturers of IGF1
Table 5. Global Insulin Like Growth Factor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Insulin Like Growth Factor Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Insulin Like Growth Factor Sales by Region (2017-2022) & (K MT)
Table 8. Global Insulin Like Growth Factor Sales Market Share by Region (2017-2022)
Table 9. Global Insulin Like Growth Factor Sales by Region (2023-2028) & (K MT)
Table 10. Global Insulin Like Growth Factor Sales Market Share by Region (2023-2028)
Table 11. Global Insulin Like Growth Factor Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Insulin Like Growth Factor Revenue Market Share by Region (2017-2022)
Table 13. Global Insulin Like Growth Factor Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Insulin Like Growth Factor Revenue Market Share by Region (2023-2028)
Table 15. Global Insulin Like Growth Factor Sales by Manufacturers (2017-2022) & (K MT)
Table 16. Global Insulin Like Growth Factor Sales Share by Manufacturers (2017-2022)
Table 17. Global Insulin Like Growth Factor Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Insulin Like Growth Factor Revenue Share by Manufacturers (2017-2022)
Table 19. Insulin Like Growth Factor Price by Manufacturers (2017-2022) &(USD/MT)
Table 20. Global Insulin Like Growth Factor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Insulin Like Growth Factor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Like Growth Factor as of 2021)
Table 22. Insulin Like Growth Factor Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Insulin Like Growth Factor Product Offered
Table 24. Date of Manufacturers Enter into Insulin Like Growth Factor Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Insulin Like Growth Factor Sales by Type (2017-2022) & (K MT)
Table 27. Global Insulin Like Growth Factor Sales by Type (2023-2028) & (K MT)
Table 28. Global Insulin Like Growth Factor Sales Share by Type (2017-2022)
Table 29. Global Insulin Like Growth Factor Sales Share by Type (2023-2028)
Table 30. Global Insulin Like Growth Factor Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Insulin Like Growth Factor Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Insulin Like Growth Factor Revenue Share by Type (2017-2022)
Table 33. Global Insulin Like Growth Factor Revenue Share by Type (2023-2028)
Table 34. Insulin Like Growth Factor Price by Type (2017-2022) & (USD/MT)
Table 35. Global Insulin Like Growth Factor Price Forecast by Type (2023-2028) & (USD/MT)
Table 36. Global Insulin Like Growth Factor Sales by Application (2017-2022) & (K MT)
Table 37. Global Insulin Like Growth Factor Sales by Application (2023-2028) & (K MT)
Table 38. Global Insulin Like Growth Factor Sales Share by Application (2017-2022)
Table 39. Global Insulin Like Growth Factor Sales Share by Application (2023-2028)
Table 40. Global Insulin Like Growth Factor Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Insulin Like Growth Factor Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Insulin Like Growth Factor Revenue Share by Application (2017-2022)
Table 43. Global Insulin Like Growth Factor Revenue Share by Application (2023-2028)
Table 44. Insulin Like Growth Factor Price by Application (2017-2022) & (USD/MT)
Table 45. Global Insulin Like Growth Factor Price Forecast by Application (2023-2028) & (USD/MT)
Table 46. North America Insulin Like Growth Factor Sales by Type (2017-2022) & (K MT)
Table 47. North America Insulin Like Growth Factor Sales by Type (2023-2028) & (K MT)
Table 48. North America Insulin Like Growth Factor Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Insulin Like Growth Factor Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Insulin Like Growth Factor Sales by Application (2017-2022) & (K MT)
Table 51. North America Insulin Like Growth Factor Sales by Application (2023-2028) & (K MT)
Table 52. North America Insulin Like Growth Factor Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Insulin Like Growth Factor Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Insulin Like Growth Factor Sales by Country (2017-2022) & (K MT)
Table 55. North America Insulin Like Growth Factor Sales by Country (2023-2028) & (K MT)
Table 56. North America Insulin Like Growth Factor Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Insulin Like Growth Factor Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Insulin Like Growth Factor Sales by Type (2017-2022) & (K MT)
Table 59. Europe Insulin Like Growth Factor Sales by Type (2023-2028) & (K MT)
Table 60. Europe Insulin Like Growth Factor Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Insulin Like Growth Factor Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Insulin Like Growth Factor Sales by Application (2017-2022) & (K MT)
Table 63. Europe Insulin Like Growth Factor Sales by Application (2023-2028) & (K MT)
Table 64. Europe Insulin Like Growth Factor Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Insulin Like Growth Factor Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Insulin Like Growth Factor Sales by Country (2017-2022) & (K MT)
Table 67. Europe Insulin Like Growth Factor Sales by Country (2023-2028) & (K MT)
Table 68. Europe Insulin Like Growth Factor Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Insulin Like Growth Factor Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Insulin Like Growth Factor Sales by Type (2017-2022) & (K MT)
Table 71. Asia Pacific Insulin Like Growth Factor Sales by Type (2023-2028) & (K MT)
Table 72. Asia Pacific Insulin Like Growth Factor Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Insulin Like Growth Factor Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Insulin Like Growth Factor Sales by Application (2017-2022) & (K MT)
Table 75. Asia Pacific Insulin Like Growth Factor Sales by Application (2023-2028) & (K MT)
Table 76. Asia Pacific Insulin Like Growth Factor Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Insulin Like Growth Factor Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Insulin Like Growth Factor Sales by Region (2017-2022) & (K MT)
Table 79. Asia Pacific Insulin Like Growth Factor Sales by Region (2023-2028) & (K MT)
Table 80. Asia Pacific Insulin Like Growth Factor Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Insulin Like Growth Factor Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Insulin Like Growth Factor Sales by Type (2017-2022) & (K MT)
Table 83. Latin America Insulin Like Growth Factor Sales by Type (2023-2028) & (K MT)
Table 84. Latin America Insulin Like Growth Factor Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Insulin Like Growth Factor Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Insulin Like Growth Factor Sales by Application (2017-2022) & (K MT)
Table 87. Latin America Insulin Like Growth Factor Sales by Application (2023-2028) & (K MT)
Table 88. Latin America Insulin Like Growth Factor Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Insulin Like Growth Factor Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Insulin Like Growth Factor Sales by Country (2017-2022) & (K MT)
Table 91. Latin America Insulin Like Growth Factor Sales by Country (2023-2028) & (K MT)
Table 92. Latin America Insulin Like Growth Factor Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Insulin Like Growth Factor Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Insulin Like Growth Factor Sales by Type (2017-2022) & (K MT)
Table 95. Middle East and Africa Insulin Like Growth Factor Sales by Type (2023-2028) & (K MT)
Table 96. Middle East and Africa Insulin Like Growth Factor Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Insulin Like Growth Factor Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Insulin Like Growth Factor Sales by Application (2017-2022) & (K MT)
Table 99. Middle East and Africa Insulin Like Growth Factor Sales by Application (2023-2028) & (K MT)
Table 100. Middle East and Africa Insulin Like Growth Factor Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Insulin Like Growth Factor Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Insulin Like Growth Factor Sales by Country (2017-2022) & (K MT)
Table 103. Middle East and Africa Insulin Like Growth Factor Sales by Country (2023-2028) & (K MT)
Table 104. Middle East and Africa Insulin Like Growth Factor Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Insulin Like Growth Factor Revenue by Country (2023-2028) & (US$ Million)
Table 106. Boehringer Ingelheim GmbH Corporation Information
Table 107. Boehringer Ingelheim GmbH Description and Major Businesses
Table 108. Boehringer Ingelheim GmbH Insulin Like Growth Factor Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 109. Boehringer Ingelheim GmbH Insulin Like Growth Factor Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Boehringer Ingelheim GmbH Recent Developments
Table 111. Genervon Biopharmaceuticals LLC Corporation Information
Table 112. Genervon Biopharmaceuticals LLC Description and Major Businesses
Table 113. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 114. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Genervon Biopharmaceuticals LLC Recent Developments
Table 116. MedImmune LLC Corporation Information
Table 117. MedImmune LLC Description and Major Businesses
Table 118. MedImmune LLC Insulin Like Growth Factor Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 119. MedImmune LLC Insulin Like Growth Factor Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. MedImmune LLC Recent Developments
Table 121. Regulaxis SAS Corporation Information
Table 122. Regulaxis SAS Description and Major Businesses
Table 123. Regulaxis SAS Insulin Like Growth Factor Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 124. Regulaxis SAS Insulin Like Growth Factor Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Regulaxis SAS Recent Developments
Table 126. Key Raw Materials Lists
Table 127. Raw Materials Key Suppliers Lists
Table 128. Insulin Like Growth Factor Distributors List
Table 129. Insulin Like Growth Factor Customers List
Table 130. Insulin Like Growth Factor Market Trends
Table 131. Insulin Like Growth Factor Market Drivers
Table 132. Insulin Like Growth Factor Market Challenges
Table 133. Insulin Like Growth Factor Market Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Like Growth Factor Product Picture
Figure 3. Global Insulin Like Growth Factor Market Share by Type in 2021 & 2028
Figure 3. Mechano Growth Factor Product Picture
Figure 4. Somatomedin C Product Picture
Figure 5. IGF1 Product Picture
Figure 6. Global Insulin Like Growth Factor Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Medical Center
Figure 9. Insulin Like Growth Factor Report Years Considered
Figure 10. Global Insulin Like Growth Factor Sales 2017-2028 (K MT)
Figure 11. Global Insulin Like Growth Factor Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Insulin Like Growth Factor Revenue 2017-2028 (US$ Million)
Figure 13. Global Insulin Like Growth Factor Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Insulin Like Growth Factor Sales Market Share by Region (2017-2022)
Figure 15. Global Insulin Like Growth Factor Sales Market Share by Region (2023-2028)
Figure 16. North America Insulin Like Growth Factor Sales YoY (2017-2028) & (K MT)
Figure 17. North America Insulin Like Growth Factor Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Insulin Like Growth Factor Sales YoY (2017-2028) & (K MT)
Figure 19. Europe Insulin Like Growth Factor Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Insulin Like Growth Factor Sales YoY (2017-2028) & (K MT)
Figure 21. Asia-Pacific Insulin Like Growth Factor Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Insulin Like Growth Factor Sales YoY (2017-2028) & (K MT)
Figure 23. Latin America Insulin Like Growth Factor Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Insulin Like Growth Factor Sales YoY (2017-2028) & (K MT)
Figure 25. Middle East & Africa Insulin Like Growth Factor Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Insulin Like Growth Factor Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Insulin Like Growth Factor in the World: Market Share by Insulin Like Growth Factor Revenue in 2021
Figure 28. Global Insulin Like Growth Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Insulin Like Growth Factor Sales Market Share by Type (2017-2028)
Figure 30. Global Insulin Like Growth Factor Revenue Market Share by Type (2017-2028)
Figure 31. Global Insulin Like Growth Factor Sales Market Share by Application (2017-2028)
Figure 32. Global Insulin Like Growth Factor Revenue Market Share by Application (2017-2028)
Figure 33. North America Insulin Like Growth Factor Sales Market Share by Type (2017-2028)
Figure 34. North America Insulin Like Growth Factor Revenue Market Share by Type (2017-2028)
Figure 35. North America Insulin Like Growth Factor Sales Market Share by Application (2017-2028)
Figure 36. North America Insulin Like Growth Factor Revenue Market Share by Application (2017-2028)
Figure 37. North America Insulin Like Growth Factor Sales Share by Country (2017-2028)
Figure 38. North America Insulin Like Growth Factor Revenue Share by Country (2017-2028)
Figure 39. U.S. Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Insulin Like Growth Factor Sales Market Share by Type (2017-2028)
Figure 42. Europe Insulin Like Growth Factor Revenue Market Share by Type (2017-2028)
Figure 43. Europe Insulin Like Growth Factor Sales Market Share by Application (2017-2028)
Figure 44. Europe Insulin Like Growth Factor Revenue Market Share by Application (2017-2028)
Figure 45. Europe Insulin Like Growth Factor Sales Share by Country (2017-2028)
Figure 46. Europe Insulin Like Growth Factor Revenue Share by Country (2017-2028)
Figure 47. Germany Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 48. France Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Insulin Like Growth Factor Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Insulin Like Growth Factor Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Insulin Like Growth Factor Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Insulin Like Growth Factor Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Insulin Like Growth Factor Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Insulin Like Growth Factor Revenue Share by Region (2017-2028)
Figure 58. China Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 61. India Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Insulin Like Growth Factor Sales Market Share by Type (2017-2028)
Figure 69. Latin America Insulin Like Growth Factor Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Insulin Like Growth Factor Sales Market Share by Application (2017-2028)
Figure 71. Latin America Insulin Like Growth Factor Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Insulin Like Growth Factor Sales Share by Country (2017-2028)
Figure 73. Latin America Insulin Like Growth Factor Revenue Share by Country (2017-2028)
Figure 74. Mexico Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Insulin Like Growth Factor Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Insulin Like Growth Factor Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Insulin Like Growth Factor Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Insulin Like Growth Factor Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Insulin Like Growth Factor Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Insulin Like Growth Factor Revenue Share by Country (2017-2028)
Figure 83. Turkey Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 85. U.A.E Insulin Like Growth Factor Revenue (2017-2028) & (US$ Million)
Figure 86. Insulin Like Growth Factor Value Chain
Figure 87. Insulin Like Growth Factor Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

以下、関連資料のご紹介

携帯型インシュリンククーラーケースのグローバル市場インサイト・予測（～2028年）

Pages
...

表皮成長因子（EGF）のグローバル市場 2021年：企業別、地域別、種類・用途別

Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-203B16150 2021年12月 87Pages
表皮成長因子（EGF）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供しま...

パルスチェイス解析のグローバル市場インサイト・予測（～2028年）

Global Pulse-chase Analysis Market Insights, Forecast to 2028
QY2203B04973 2022年3月 79Pages
新型コロナウイルス感染症のパンデミックにより、世界のパルスチェイス解析の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にパルスチェイス解析...

過活動膀胱（OAB）治療のグローバル市場インサイト・予測（～2028年）

Global Overactive Bladder Treatment Market Insights and Forecast to 2028
QY2203B08096 2022年3月 91Pages
新型コロナウイルス感染症のパンデミックにより、世界の過活動膀胱（OAB）治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に過活動膀胱（...

埋立ガス(LFG)のグローバル市場インサイト・予測（～2028年）

Global Landfill Gas (LFG) Market Insights and Forecast to 2028
QY2203B13853 2022年3月 113Pages
新型コロナウイルス感染症のパンデミックにより、世界の埋立ガス(LFG)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に埋立ガス(LFG)...

トラックテレマティクスのグローバル市場インサイト・予測（～2028年）

Global Truck Telematics Market Insights and Forecast to 2028
QY2203B04395 2022年3月 111Pages
新型コロナウイルス感染症のパンデミックにより、世界のトラックテレマティクスの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にトラックテレマ...

ガス供給システムのグローバル市場インサイト・予測（～2028年）

Global Gas Distribution Systems Market Insights, Forecast to 2028
QY2203B02256 2022年3月 114Pages
新型コロナウイルス感染症のパンデミックにより、世界のガス供給システムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にガス供給システムの世...

幹細胞治療のグローバル市場インサイト・予測（～2028年）

Global Stem Cell Therapy Market Insights and Forecast to 2028
QY2203B08258 2022年3月 95Pages
新型コロナウイルス感染症のパンデミックにより、世界の幹細胞治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に幹細胞治療の世界市場のxx...

VHFデータ交換システム（VDES）のグローバル市場インサイト・予測（～2028年）

Global VHF Data Exchange System Market Insights and Forecast to 2028
QY2203B01213 2022年3月 109Pages
新型コロナウイルス感染症のパンデミックにより、世界のVHFデータ交換システム（VDES）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に...

ラフティングパドルのグローバル市場インサイト・予測（～2028年）

Global Rafting Paddles Market Insights, Forecast to 2028
QY2203B06882 2022年3月 108Pages
新型コロナウイルス感染症のパンデミックにより、世界のラフティングパドルの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にラフティングパドル...

表皮成長因子（EGF）のグローバル市場 2021年：企業別、地域別、種類・用途別 The Epidermal Growth Factor (EGF) (CAS 62253-63-8) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
携帯型インシュリンククーラーケースのグローバル市場インサイト・予測（～2028年） A box that keeps insulin in a safe and cool environment. Market Analysis and Insights: Global Portable Insulin Cooler Cases Market Due to the COVID-19 pandemic, the global Portable Insulin Cooler Cases market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of U…
バイオシミラーインスリングラルギンのグローバル市場 2021年：企業別、地域別、種類・用途別 The Biosimilar Insulin Glargine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
インスリンのグローバル市場 2021年：企業別、地域別、種類・用途別 The Insulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent dev…
ヒト血液凝固第VIII因子のグローバル市場 2021年：企業別、地域別、種類・用途別 The Human Coagulation Factor VIII market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…